Cargando…
Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
BACKGROUND: Familial hypercholesterolemia (FH) leads to elevated low-density lipoprotein cholesterol (LDL-C) levels in plasma. Mutations of its related gene; apolipoprotein B (APOB) is seen in about two percent of the patient with FH. Thyroid disease is usually part of the exclusion criteria for the...
Autores principales: | Vaseghi, Golnaz, Malakoutikhah, Zahra, Shafiee, Zahra, Gharipour, Mojgan, Shariati, Laleh, Sadeghian, Ladan, Khosravi, Elham, Javanmard, Shaghayegh Haghjooy, Pourmoghaddas, Ali, Laher, Ismail, Zarfeshani, Sonia, Sarrafzadegan, Nizal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607183/ https://www.ncbi.nlm.nih.gov/pubmed/34899932 http://dx.doi.org/10.4103/jrms.JRMS_970_19 |
Ejemplares similares
-
CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
por: Vaseghi, Golnaz, et al.
Publicado: (2019) -
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021) -
Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia
por: Vaseghi, Golnaz, et al.
Publicado: (2022) -
Determining genetic variants in children and adolescents suffering from Tetralogy of Fallot with a positive family history: methodology
por: Sabri, Mohammad Reza, et al.
Publicado: (2020) -
Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023)